. Author manuscript; available in PMC: 2011 Sep 1.

Published in final edited form as: J Alzheimers Dis. 2011 Jan 1;26(1):127–134. doi: 10.3233/JAD-2011-110086

Table 2.

Prevalence of vascular factors by Apoe E4 genotype (any vs. none) among participants with at least one follow-up (n=216)

Vascular Factor		No E4 (n=119)	Any E4 (1 or 2) (n=97)	p-value
Vascular Factor		N/(%)	N/(%)	p-value
SBP >=140:	Present	24 (22.2%)	19 (23.2%)	1.000
SBP >=140:	Absent	84 (77.8%)	63 (76.8%)	1.000
Atrial Fibrillation:	Present	19 (16.0%)	9 (9.3%)	0.160
Atrial Fibrillation:	Absent	100 (84.0%)	88 (90.7%)	0.160
Angina:	Present	16 (13.6%)	13 (13.4%)	1.000
Angina:	Absent	102 (86.4%)	84 (86.6%)	1.000
MI:	Present	14 (11.8%))	11 (11.3%)	1.000
MI:	Absent	105 (88.2%)	86 (88.7%)	1.000
CABG:	Present	7 (5.8%)	3 (3.1%)	0.517
CABG:	Absent	112 (94.1%)	94 (96.9%)	0.517
Diabetes:	Present	22 (18.5%)	13 (13.4%)	0.357
Diabetes:	Absent	97 (81.5%)	84 (86.6%)	0.357
Current Anti-htn Med:	Present	48 (40.3%)	45 (47.4%)	0.335
Current Anti-htn Med:	Absent	71 (59.7%)	51 (52.6%)	0.335
Stroke:	Present	4 (3.4%)	4 (4.1%)	1.000
Stroke:	Absent	115 (96.6%)	93 (95.9%)	1.000

p-value based on Fischer’s Exact test